Ocugen Inc. Announces Closing of $100 Million Registered Direct Offering of Common Stock Priced at a Premium to MarketGlobeNewsWire • 04/28/21
If You Want to Roll the Dice on Ocugen Stock, Understand the Game You're PlayingInvestorPlace • 04/26/21
Ocugen's COVID-19 Vaccine Partner To Charge Twice As Much As Main Indian Rival AstrazenecaBenzinga • 04/26/21
3 Stocks That Turned $250,000 Into $1 Million (or More) Since the Year BeganThe Motley Fool • 04/25/21
Here's Why Ocugen Stock Rocketed 47% Today -- and Then Gave Up Almost All Its GainsThe Motley Fool • 04/24/21
Ocugen Inc. Announces $100 Million Registered Direct Offering of Common Stock Priced at a Premium to MarketGlobeNewsWire • 04/23/21